During the past decade, Saint Mary's Oncology/Hematology Associates of West Branch conducted 120 clinical trials. In the 10-year time frame, 120 clinical trials started and 30 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 56 clinical trials started and 30 clinical trials were completed. i.e. 53.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Mary's Oncology/Hematology Associates of West Branch" #1 sponsor was "National Cancer Institute (NCI)" with 66 trials, followed by "Alliance for Clinical Trials in Oncology" with 27 trials sponsored, "SWOG Cancer Research Network" with 20 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored and "NRG Oncology" with 12 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Mary's Oncology/Hematology Associates of West Branch" #1 collaborator was "National Cancer Institute (NCI)" with 70 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Saint Mary's Oncology/Hematology Associates of West Branch" are "Stage IV Lung Cancer AJCC v8" (8 trials), "Invasive Breast Carcinoma" (5 trials), "Recurrent Lung Non-Small Cell Carcinoma" (5 trials), "Stage IIIB Lung Cancer AJCC v8" (5 trials) and "Stage IV Breast Cancer AJCC v6 and v7" (5 trials). Many other conditions were trialed in "Saint Mary's Oncology/Hematology Associates of West Branch" in a lesser frequency.

Most popular intervention types in "Saint Mary's Oncology/Hematology Associates of West Branch" are "Drug" (109 trials), "Other" (81 trials), "Biological" (53 trials), "Procedure" (42 trials) and "Radiation" (16 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (41 trials), "Laboratory Biomarker Analysis" (28 trials), "Questionnaire Administration" (28 trials), "Biospecimen Collection" (26 trials) and "Computed Tomography" (25 trials). Other intervention names were less common.

The vast majority of trials in "Saint Mary's Oncology/Hematology Associates of West Branch" are 120 trials for "All" genders, 15 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Mary's Oncology/Hematology Associates of West Branch". undefined are not yet recruiting, 52 are recruiting, 62 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Saint Mary's Oncology/Hematology Associates of West Branch, 6 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Mary's Oncology/Hematology Associates of West Branch, 2 "Phase 1" clinical trials were conducted, 69 "Phase 2" clinical trials and 74 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".